5 Recruiting Classical Hodgkin Lymphoma Phase 2 Clinical Trials

Active phase 2 studies for classical hodgkin lymphoma enrolling across the USA. Verify eligibility and contact site coordinators.

All Classical Hodgkin Lymphoma studies

Phase 2 Studies for Classical Hodgkin Lymphoma

🔵 Active, Not Recruiting Phase2

Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above

📍 Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey

View Study & Checklist ➔

🟡 Not Yet Recruiting Phase1 / Phase2

CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma

📍 New York Medical College — Valhalla, New York

View Study & Checklist ➔

🟢 Recruiting Phase2

Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma

📍 Princess Margaret Cancer Centre — Toronto, Ontario

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2

Itacitinib + Everolimus in Hodgkin Lymphoma

📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2

Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

📍 Winship Cancer Center of Emory University — Atlanta, Georgia

View Study & Checklist ➔